| Released | Contributor | Author | Title | Pages | Price |
|---|
| May 27, 2013 | Market Edge | N/A | Market Edge Equity Research Report | 4 | $10 | | May 27, 2013 | Alpha Street Research | Hunter Orr | WCRX - Warner Chilcott Plc - Upgraded to a Buy - Company Analysis and ASR Ranking Report | 9 | $24 | | May 24, 2013 | Wright Reports | N/A | Wright Investors Service Comprehensive Report for Warner Chilcott Plc | 41 | $471.50 | | May 24, 2013 | Pechala's Reports | Frantisek Pechala | WARNER CHILCOTT LTD CL A (WCRX) 12-months forecast | 1 | $15 | | May 23, 2013 | ValuEngine, Inc. | N/A | ValuEngine Industry Report for Medical-drugs | 18 | $207 | | May 23, 2013 | Ford Investor Services, Inc. | N/A | Industry Value Graph: RDY , ELN , ENDP , IPXL , IRWD , MYL , VRX , WCRX -- DRUGS | 3 | $34.50 | | May 23, 2013 | Ford Investor Services, Inc. | N/A | Value Graph: WARNER CHILCOTT -- WCRX | 1 | $11.50 | | May 22, 2013 | ValuEngine, Inc. | N/A | ValuEngine Detailed Valuation Report for WCRX | 11 | $126.50 | | May 22, 2013 | S&P Capital IQ – STARS Reports | N/A | Warner Chilcott'A' | 10 | $115 | | May 19, 2013 | New Constructs, LLC | N/A | WCRX: Due Diligence Review: Forensic Earnings and Valuation | 13 | $25 |
|
View All Reports for WCRX ... |
|
|
0.04(0.20%) May 24, 4:00PM EDT|After Hours
:
19.93